REGENARP
LIVE

Serial Number

97109345

Owner

REGENLAB USA LLC

Attorney

Lindsay Kaplan

Filing Date

Nov 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

REGENARP Trademark

Serial Number: 97109345

REGENARP is a trademark filed by REGENLAB USA LLC on November 4, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

REGENLAB USA LLC

95 Greene Street
Jersey City, NJ 07302

Entity Type: 16

Trademark Details

Filing Date

November 4, 2021

Registration Date

Not Registered

Published for Opposition

July 11, 2023

Goods & Services

Medical apparatus and instruments for use in the treatment and prevention of diseases caused by viruses; Medical apparatus and instruments for use in non-surgical dentistry, orthopedic, cosmetic, esthetic, ophthalmology and mesotherapy procedures; suture materials; syringes for injections; cases fitted for medical instruments; syringes for medical purposes; injection instruments without needles; injection instruments with needles; medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues; blood collection tubes; medical apparatus in the nature of tubing for taking blood samples; blood component separation apparatus for medical use; medical instruments for filtering blood and blood components; medical apparatus used to introduce pharmaceutical preparations into the human body, namely, medical tubing for administering drugs; medical apparatus and instruments for monitoring biological tissues, cell therapy, plasma, and antibodies

Pharmaceutical and veterinary preparations, namely, solutions for application on and under tissue, bone and organ for the purpose of promoting cellular regeneration, tissue adhesion, wound healing, bone or periodontum growth and bone, organ or tissue regeneration; sanitary preparations for medical purposes; adjuvants for medical purposes; biological preparations for medical purposes, namely, stem cells for medical purposes; medicated lotions for skin; tissues impregnated with medicated lotions for the treatment of damaged skin and tissue; medical dressings; Surgical mesh comprised primarily of living tissue; medicated skin care preparations; pharmaceutical preparations for the treatment of damaged skin tissue; medical cleansers for skin; allograft tissue reconstitution solution kits; cells for medical or clinical purposes; all-purpose disinfectants; disinfectants for hygiene purposes; kits containing chemical reagents used for medical diagnoses; culture media for cultivating human, plant and animal biological tissue cultures as well as natural DNA samples for medical and veterinary use

Filing History

SOU TEAS EXTENSION RECEIVED
Mar 2, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 22, 2025 EXRA
SOU EXTENSION 4 GRANTED
Aug 21, 2025 EX4G
SOU EXTENSION 4 FILED
Aug 21, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Aug 21, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2025 EXRA
SOU EXTENSION 3 GRANTED
Mar 3, 2025 EX3G
SOU EXTENSION 3 FILED
Mar 3, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 3, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 5, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 5, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 5, 2024 EXRA
SOU EXTENSION 2 GRANTED
Sep 5, 2024 EX2G
SOU EXTENSION 2 FILED
Sep 5, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 2, 2024 EXRA
SOU EXTENSION 1 GRANTED
Mar 1, 2024 EX1G
SOU EXTENSION 1 FILED
Mar 1, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 1, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 5, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 11, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jul 11, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 21, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 6, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 3, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 2, 2023 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2023 REAP
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 3, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 3, 2023 XELR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 10, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 10, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 10, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 10, 2023 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 5, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 3, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 8, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 8, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 8, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 10, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2021 NWOS
NEW APPLICATION ENTERED
Nov 8, 2021 NWAP